| Structure | Chemical Name | CAS | MF |
|
Cyclohexanecarboxylic acid, 2-acetyl-, (1R,2S)-rel- (9CI)
|
158430-34-3
|
C9H14O3
|
|
Ethanone, 2,2,2-trifluoro-1-(2-methoxy-1-cyclohexen-1-yl)- (9CI)
|
158432-45-2
|
C9H11F3O2
|
|
Ethanone, 2,2,2-trifluoro-1-(2-methoxy-1-cyclopenten-1-yl)- (9CI)
|
158432-46-3
|
C8H9F3O2
|
|
1-Cyclopentene-1-methanol, alpha-(dichloromethylene)-2-hydroxy- (9CI)
|
158432-50-9
|
C7H8Cl2O2
|
|
2-Chloro-4-bromobenzaldehyde
|
158435-41-7
|
C7H4BrClO
|
|
4-HYDROXY-BENZYL-HYDRAZINE
|
158438-44-9
|
C7H10N2O
|
|
4-METHYLCYCLOHEXYL-HYDRAZINE
|
158438-47-2
|
C7H16N2
|
|
2-(2-Pyridinylamino)-benzenethiol
|
158438-81-4
|
C11H10N2S
|
|
methyl 5-chloro-3-chlorosuphonylthiophene-2-carboxylate
|
158439-31-7
|
C8H7ClO6S2
|
|
2-AMINO-N'-HYDROXYBENZENECARBOXIMIDAMIDE
|
158439-80-6
|
C7H9N3O
|
|
6-Nitrospiro[1,2,3,4-tetrahydroquinazoline-2,1'-cyclopentane]-4-one
|
158439-85-1
|
C12H13N3O3
|
|
Irofulven
|
158440-71-2
|
C15H18O3
|
|
Benzene, 1-fluoro-3-(1-methyl-1-propenyl)-, (E)- (9CI)
|
158440-79-0
|
C10H11F
|
|
rac 10,14-Dimethylpentadecyl Isobutyrate
|
158442-03-6
|
C21H42O2
|
|
PROTEASOME INHIBITOR I
|
158442-41-2
|
C32H50N4O8
|
|
dorrigocin A
|
158446-29-8
|
C27H41NO8
|
|
proxodolol
|
158446-41-4
|
C17H26ClN3O5
|
|
POLYSILICONE-13
|
158451-77-5
|
|
|
|
N,N,N′,N′-Tetramethyl-1,6-hexanediamin+3 PO
|
158451-78-6
|
|
|
|
COAGULATION FACTOR XIIIA (190-230)
|
158455-48-2
|
C220H322N54O73
|
|
methyl 2-(benzyloxycarbonylamino)acetate
|
158457-27-3
|
C11H13NO3
|
|
methyl 2-{[2-(4-methoxyphenyl)ethyl]amino}acetate
|
158458-07-2
|
C12H17NO3
|
|
(2R,4R)-1-(tert-butoxycarbonyl)-4-phenoxypyrrolidine-2-carboxylic acid
|
158459-12-2
|
C16H21NO5
|
|
(4R)-1-N-BOC-4-BENZYL-D-PROLINE
|
158459-13-3
|
C17H23NO4
|
|
ethyl 2-aMino-5-tert-butylthiophene-3-carboxylate
|
158461-00-8
|
C11H17NO2S
|
|
Benzenamine, 5-ethoxy-2-(2-pyridinyl)- (9CI)
|
158461-49-5
|
C13H14N2O
|
|
Benzenamine, 5-ethoxy-2-(4-pyridinyl)- (9CI)
|
158461-65-5
|
C13H14N2O
|
|
2-Benzothiazolamine,5,7-dichloro-(9CI)
|
158465-13-5
|
C7H4Cl2N2S
|
|
|
DIACETOXYMETHYL TERMINATED POLYDIMETHYLSILOXANE
|
158465-54-4
|
|
|
(CARBOXYALKYL) TERMINATED POLYDIMETHYLSILOXANE
|
158465-59-9
|
C14H32O6Si3
|
|
|
CHLOROMETHYL TERMINATED POLYDIMETHYLSILOXANE
|
158465-60-2
|
|
|
Prohydrojasmon
|
158474-72-7
|
C15H26O3
|
|
BAND 3 PROTEIN (824-829) (HUMAN)
|
158475-15-1
|
C37H65N11O8
|
|
Peroxynitric acid, 2-oxopropyl ester (9CI)
|
158475-28-6
|
C3H5NO5
|
|
Saccharocarcin B
|
158475-33-3
|
C68H103NO20
|
|
Hexanal, 4-hydroxy-5-oxo- (9CI)
|
158478-09-2
|
C6H10O3
|
|
1 3-DI-BOC-2-(CARBOXYMETHYL)GUANIDINE
|
158478-76-3
|
C13H23N3O6
|
|
Fmoc-HomoArg(Boc)2-OH
|
158478-81-0
|
C32H42N4O8
|
|
ω-Agatoxin TK
|
158484-42-5
|
C215H337N65O70S10
|
|
2(1H)-Pyrimidinethione, 4-amino-5-ethyl- (9CI)
|
158495-86-4
|
C6H9N3S
|
|
Cnidioside B Methyl ester
|
158500-59-5
|
C19H24O10
|
|
PHENOTHIAZINE-10-ACETYL CHLORIDE
|
158502-05-7
|
C14H10ClNOS
|
|
2-CHLORO-3-ISOPROPYLPYRIDINE
|
158503-51-6
|
C8H10ClN
|
|
1,4-Benzodioxin-5-carboxylicacid,8-amino-2,3-dihydro-,methylester(9CI)
|
158504-37-1
|
C10H11NO4
|
|
Oxirane, 1-heptynyl- (9CI)
|
158504-99-5
|
C9H14O
|
|
Bicyclo[2.2.1]heptane, 2-fluoro-2-nitro-, exo- (9CI)
|
158506-26-4
|
C7H10FNO2
|
|
Bicyclo[2.2.1]heptane, 2-fluoro-2-nitro-, endo- (9CI)
|
158506-27-5
|
C7H10FNO2
|
|
cerebrodiene
|
158507-68-7
|
C18H35NO
|
|
methyl 3-oxo-2-propionylpentanoate
|
158511-22-9
|
C9H14O4
|
|
medicago-saponin P(1)
|
158511-57-0
|
C53H86O23
|
|
medicago-saponin P(2)
|
158511-58-1
|
C47H76O18
|
|
ECLALBASAPONIN I
|
158511-59-2
|
C42H68O14
|
|
ECLALBASAPONIN VI
|
158511-63-8
|
C42H68O17S
|
|
3',4'-DIMETHYL-3-PHENYLPROPIOPHENONE
|
158511-72-9
|
C17H18O
|
|
N-[N,O-ISOPROPYLIDENE-(2R)-HYDROXY INDAN-(1S)-YL]-(2R)-BENZYL-(4S,5)-EPOXY PENTANAMIDE
|
158512-24-4
|
C24H27NO3
|
|
(Dimethylsilylene)bis(2-methyl-4-phenylindenyl)zirconium dichloride
|
158515-16-3
|
C34H32Cl2SiZr-2
|
|
1,4-bis(pyridin-4-ylethynyl)benzene
|
158525-01-0
|
C20H12N2
|
|
1H-2,5-Methanocyclopenta[c]pyrrol-5(3H)-amine,tetrahydro-(9CI)
|
158525-35-0
|
C8H14N2
|
|
1H-2,5-Methanocyclopenta[c]pyrrole-5(3H)-carbonitrile,tetrahydro-(9CI)
|
158525-36-1
|
C9H12N2
|
|
Formamide, N-(3-amino-2-pyridinyl)- (9CI)
|
158525-50-9
|
C6H7N3O
|
|
3-chloro-N-(4-methoxyphenyl)benzamide
|
158525-81-6
|
C14H12ClNO2
|
|
N-(4-bromophenyl)-4-methylbenzamide
|
158525-82-7
|
C14H12BrNO
|
|
N-(4-bromophenyl)-3-chlorobenzamide
|
158525-83-8
|
C13H9BrClNO
|
|
2-(4-chlorophenyl)-5-[4-(dimethylamino)benzylidene][1,3]thiazolo[3,2-b][1,2,4]triazol-6(5H)-one
|
158525-95-2
|
C19H15ClN4OS
|
|
2-(4-chlorophenyl)-5-(4-methoxybenzylidene)[1,3]thiazolo[3,2-b][1,2,4]triazol-6(5H)-one
|
158525-97-4
|
C18H12ClN3O2S
|
|
.beta.-D-Allopyranoside, 2-(dimethylamino)-3a,5,6,6a-tetrahydro-5-hydroxy-6-(hydroxymethyl)-4H-cyclopentoxazol-4-yl 2-(acetylamino)-4-O-2-(acetylamino)-2-deoxy-.beta.-D-allopyranosyl-2-deoxy-, 3aS-(3a.alpha.,4.alpha.,5.beta.,6.alpha.,6a.alpha.)-
|
158528-74-6
|
C25H42N4O14
|
|
2-methyl-6-phenylimidazo(2,1-b)-1,3,4-thiadiazole-5-carboxaldehyde dimethylaminoacetohydrazone
|
158530-54-2
|
C16H18N6OS
|
|
3-(aminomethyl)pyridin-4-amine
|
158531-09-0
|
C6H9N3
|
|
METHYL 3-(3-BROMO-4-HYDROXY-5-METHOXYPHENYL)-2-CYANOACRYLATE
|
158532-02-6
|
C12H10BrNO4
|
|
2',3'-didehydro-2',3'-dideoxy-5-hydroxymethyluridine
|
158532-72-0
|
C10H12N2O5
|
|
|
4-(1-AMINOETHYL)PHENOL PROPOXYLATE, AVER AGE MN CA. 1,880
|
158535-45-6
|
CH3CH(NH2)C6H4(OC3H6)nOH
|
|
a-Helical Corticotropin Releasing Factor (12-41)
|
158535-55-8
|
C152H251N43O47S2
|
|
1H-Pyrido[4,3:4,5]pyrrolo[3,2:4,5]benzimidazo[1,2-c]quinazoline (9CI)
|
158537-58-7
|
C19H11N5
|
|
4H-1,3-Dioxino[4,5-b]pyridine(9CI)
|
158537-79-2
|
C7H7NO2
|
|
|
cyclin H
|
158540-26-2
|
|
|
|
trimucrin
|
158540-66-0
|
|
|
3-Pyridinecarbonitrile,2-(aminooxy)-(9CI)
|
158549-15-6
|
C6H5N3O
|
|
3-pentyl-6,7,7a,8,9,11a-hexahydro-1,7-dihydroxy-7,10-dimethyldibenzo(b,d)oxepin
|
158550-93-7
|
C21H30O3
|
|
1-(3-FLUORO-PHENYL)-PIPERIDIN-4-ONE
|
158553-31-2
|
C11H12FNO
|
|
CHEMBRDG-BB 4000320
|
158553-32-3
|
C12H15NO2
|
|
2-(2-Piperidinoethyl)-5-(4-nitrophenyl)tetrazole hydrate
|
158553-38-9
|
C14H18N6O2
|
|
6-hydroxy-4',5,7-triaminoflavone
|
158555-33-0
|
|
|
1H-Thieno[2,3-b][1,4]oxazin-2(3H)-one
|
158560-72-6
|
C6H5NO2S
|
|
H-HIS-HIS-GLY-VAL-VAL-GLU-VAL-ASP-ALA-ALA-VAL-THR-PRO-GLU-GLU-ARG-HIS-LEU-SER-LYS-OH
|
158561-91-2
|
C95H152N30O31
|
|
1,3,5,7-tetrakis(4-aminophenyl)adamantane
|
158562-40-4
|
C34H36N4
|
|
HEXADECANE-1,2-13C2
|
158563-27-0
|
C16H34
|
|
Nonapeptide-1
|
158563-45-2
|
C61H87N15O9S
|
|
OCTYLDODECYL NEOPENTANOATE
|
158567-66-9
|
C25H50O2
|
|
(2R,4R)-Boc-4-phenyl-pyrrolidine-2-carboxylic acid
|
158567-91-0
|
C16H21NO4
|
|
(2S,5R)-5-PHENYLPYRROLIDINE-2-CARBOXYLIC ACID
|
158567-93-2
|
C13H17NO2
|
|
Bicyclo[2.2.1]heptane-2-carboxylic acid, 2-hydroxy-, (1S-exo)- (9CI)
|
158568-27-5
|
C8H12O3
|
|
1-Azabicyclo[2.2.2]octan-3-ol, 3-(mercaptomethyl)-, (S)- (9CI)
|
158568-64-0
|
C8H15NOS
|
|
DL-BETA-HOMOMETHIONINE
|
158570-14-0
|
C6H13NO2S
|
|
|
EMU OIL
|
158570-96-8
|
|
|
|
mixed linear and branched C14-15 alcohols ethoxylated, reaction product with epichlorohydrin
|
158570-99-1
|
|
|
|
Disperse orange 118
|
158571-45-0
|
|
|
|
Reactive red 243
|
158571-46-1
|
|
|
|
HC BLUE NO. 4
|
158571-57-4
|
|
|
|
HC BLUE NO. 5
|
158571-58-5
|
|
|
Bis-pentafluorophenyl diglycolic acid, 2,2-Oxydiacetic acid bis-pentafluorophenyl ester
|
158573-58-1
|
C16H4F10O5
|